RxDoctor Payments Data

Ashleigh Arrowood, APRN

Psychiatric/Mental Health · Columbus, OHNPI 1477228195

Payments from drug & device makers

$475in general payments, 2019–2025

Across 22 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$92
  • AbbVie$84
  • Supernus Pharmaceuticals, Inc.$74
  • Axsome Therapeutics, Inc.$46
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$43
  • Collegium Pharmaceutical, Inc.$38
  • plus $97 from 4 others

What the payments were for

  • Food & beverage$475100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$475 in reported general payments places this provider in the 40th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$4,603
Medicare patients
13
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate12$19,620
VyvanseLisdexamfetamine Dimesylate23$8,444
Aripiprazole35$1,558
Buspirone Hcl44$659
Quetiapine Fumarate34$476
Venlafaxine Hcl ErVenlafaxine Hcl20$406
Bupropion XlBupropion Hcl38$351
Sertraline Hcl13$340
Gabapentin18$308
Lamotrigine44$254
Trazodone Hcl37$203
Bupropion Hcl SrBupropion Hcl15$191
Duloxetine Hcl16$181
Escitalopram Oxalate24$168
Lithium Carbonate ErLithium Carbonate16$164

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$43$19,62012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →